382 related articles for article (PubMed ID: 14978234)
1. Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1.
Chang C; Swaan PW; Ngo LY; Lum PY; Patil SD; Unadkat JD
Mol Pharmacol; 2004 Mar; 65(3):558-70. PubMed ID: 14978234
[TBL] [Abstract][Full Text] [Related]
2. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Lang TT; Young JD; Cass CE
Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
[TBL] [Abstract][Full Text] [Related]
3. Cation coupling properties of human concentrative nucleoside transporters hCNT1, hCNT2 and hCNT3.
Smith KM; Slugoski MD; Cass CE; Baldwin SA; Karpinski E; Young JD
Mol Membr Biol; 2007; 24(1):53-64. PubMed ID: 17453413
[TBL] [Abstract][Full Text] [Related]
4. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
5. Renal nucleoside transporters: physiological and clinical implications.
Elwi AN; Damaraju VL; Baldwin SA; Young JD; Sawyer MB; Cass CE
Biochem Cell Biol; 2006 Dec; 84(6):844-58. PubMed ID: 17215872
[TBL] [Abstract][Full Text] [Related]
6. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.
Govindarajan R; Endres CJ; Whittington D; LeCluyse E; Pastor-Anglada M; Tse CM; Unadkat JD
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G570-80. PubMed ID: 18635603
[TBL] [Abstract][Full Text] [Related]
7. Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney.
Damaraju VL; Elwi AN; Hunter C; Carpenter P; Santos C; Barron GM; Sun X; Baldwin SA; Young JD; Mackey JR; Sawyer MB; Cass CE
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F200-11. PubMed ID: 17409283
[TBL] [Abstract][Full Text] [Related]
8. Role of human nucleoside transporters in the cellular uptake of two inhibitors of IMP dehydrogenase, tiazofurin and benzamide riboside.
Damaraju VL; Visser F; Zhang J; Mowles D; Ng AM; Young JD; Jayaram HN; Cass CE
Mol Pharmacol; 2005 Jan; 67(1):273-9. PubMed ID: 15486050
[TBL] [Abstract][Full Text] [Related]
9. Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1.
Lepist EI; Damaraju VL; Zhang J; Gati WP; Yao SY; Smith KM; Karpinski E; Young JD; Leung KH; Cass CE
Drug Metab Dispos; 2013 Apr; 41(4):916-22. PubMed ID: 23388705
[TBL] [Abstract][Full Text] [Related]
10. Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
Visser F; Zhang J; Raborn RT; Baldwin SA; Young JD; Cass CE
Mol Pharmacol; 2005 Apr; 67(4):1291-8. PubMed ID: 15644498
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
12. Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.
Cano-Soldado P; Pastor-Anglada M
Med Res Rev; 2012 Mar; 32(2):428-57. PubMed ID: 21287570
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems.
King KM; Damaraju VL; Vickers MF; Yao SY; Lang T; Tackaberry TE; Mowles DA; Ng AM; Young JD; Cass CE
Mol Pharmacol; 2006 Jan; 69(1):346-53. PubMed ID: 16234483
[TBL] [Abstract][Full Text] [Related]
14. Uridine binding motifs of human concentrative nucleoside transporters 1 and 3 produced in Saccharomyces cerevisiae.
Zhang J; Visser F; Vickers MF; Lang T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
Mol Pharmacol; 2003 Dec; 64(6):1512-20. PubMed ID: 14645682
[TBL] [Abstract][Full Text] [Related]
15. Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: High-affinity inhibitors of human concentrative nucleoside transporter 1.
Damaraju VL; Smith KM; Mowles D; Nowak I; Karpinski E; Young JD; Robins MJ; Cass CE
Biochem Pharmacol; 2011 Jan; 81(1):82-90. PubMed ID: 20854794
[TBL] [Abstract][Full Text] [Related]
16. Studies of nucleoside transporters using novel autofluorescent nucleoside probes.
Zhang J; Sun X; Smith KM; Visser F; Carpenter P; Barron G; Peng Y; Robins MJ; Baldwin SA; Young JD; Cass CE
Biochemistry; 2006 Jan; 45(4):1087-98. PubMed ID: 16430205
[TBL] [Abstract][Full Text] [Related]
17. The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.
Clarke ML; Damaraju VL; Zhang J; Mowles D; Tackaberry T; Lang T; Smith KM; Young JD; Tomkinson B; Cass CE
Mol Pharmacol; 2006 Jul; 70(1):303-10. PubMed ID: 16617163
[TBL] [Abstract][Full Text] [Related]
18. HPLC reveals novel features of nucleoside and nucleobase homeostasis, nucleoside metabolism and nucleoside transport.
Altaweraqi RA; Yao SYM; Smith KM; Cass CE; Young JD
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183247. PubMed ID: 32126230
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
[TBL] [Abstract][Full Text] [Related]
20. Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity.
Paproski RJ; Visser F; Zhang J; Tackaberry T; Damaraju V; Baldwin SA; Young JD; Cass CE
Biochem J; 2008 Sep; 414(2):291-300. PubMed ID: 18462193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
